Policy ForumBiomedical Innovation

How economics can shape precision medicines

See allHide authors and affiliations

Science  17 Mar 2017:
Vol. 355, Issue 6330, pp. 1131-1133
DOI: 10.1126/science.aai8707

Article Information

vol. 355 no. 6330 1131-1133

PubMed: 
Print ISSN: 
Online ISSN: 
History: 

    Author Information

    1. A. D. Stern1,2,
    2. B. M. Alexander3,4,
    3. A. Chandra1,5,6
    1. 1Harvard Business School, Boston, MA 02163, USA.
    2. 2Ariadne Labs at Brigham and Women's Hospital and the Harvard T. H. Chan School of Public Health, Boston, MA 02215, USA.
    3. 3Dana-Farber Cancer Institute, Boston, MA 02215, USA.
    4. 4Harvard Program in Therapeutic Science, Harvard Medical School, Boston, MA 02115, USA.
    5. 5Harvard Kennedy School, Cambridge, MA 02138, USA.
    6. 6National Bureau of Economic Research, Cambridge, MA 02138, USA.
    1. Email: astern{at}hbs.edu

    Altmetric

    Article usage

    Article usage: March 2017 to December 2017

    AbstractFullPdf
    Mar 2017203208261151
    Apr 2017839184252
    May 2017382104124
    Jun 20172245087
    Jul 20171974097
    Aug 20172024878
    Sep 20171944555
    Oct 20172436242
    Nov 20171977354
    Dec 201740137